About
Greg Rhee, PhD, is an Adjunct Associate Professor of Medicine (Psychiatry) and Public Health (Epidemiology and Biostatistics) at Yale University. His expertise lies in pharmaco-epidemiology and mental health services research, focusing on suicide prevention, mood disorders, and substance use disorders. He holds an adjunct appointment at the VA Connecticut Healthcare System and is a Senior Investigator at the Institute for Health Metrics and Evaluation (IHME).
Education: PhD in Epidemiology (University of Minnesota, 2017), MA in Sociology (University of Chicago, 2011), AB in Sociology (Emory University, 2008). NIH Postdoctoral Fellowship in Mental Health Services Research (Yale, 2019).
Research interests include comparative effectiveness of treatments, observational studies using large datasets (e.g., Medicare/Medicaid), and systematic reviews. Key areas: suicide epidemiology, ketamine therapies, and healthcare policy.
His 250+ peer-reviewed articles address topics like suicide prevention strategies, antidepressant efficacy, and industry payment trends among psychiatrists. Notable collaborations include work with Joseph Ross, Robert Rosenheck, and Samuel Wilkinson.
Awards: Fellow of the American College of Epidemiology (2022), Delta Omega (2023), and multiple NIH-funded grants. Serves on editorial boards for JAMA Psychiatry and Depression and Anxiety.
Current roles: Principal Investigator on NIH/AHRQ grants, mentor for junior researchers, and advisor on health equity initiatives.